Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya — Stella

Home/Cholera Vaccination/

View on ClinicalTrials.gov

Recruiting

Back to Cholera Vaccination trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Kenya

KEMRI, Nairobi

Key details

Phase

Post-approval study

Sponsor

Albert B. Sabin Vaccine Institute

Collaborators

Kenya Medical Research Institute, Washington State University

Enrollment target

~1,071 participants

Started

October 2025

Primary completion

June 2028

Age range

1 Year and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.